drugset
drugset / Trial / NCT01925300

Pharmacokinetic Interactions of Bisoprolol and Rosuvastatin

NCT01925300 ↗

Phase 1 Withdrawn HK inno.N Corporation
RandomizedCrossoverOpen-labelBasic science

Summary

This study is designated to evaluate the pharmacokinetic interactions of bisoprolol and rosuvastatin in healthy male volunteers.

Timeline

Start
2013-07
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bisoprolol Other / unclassified 5 mg Oral
Subject Rosuvastatin Small molecule 20 mg Oral

Indications

No indication recorded.